Skip to main content
Top
Published in: The Journal of Obstetrics and Gynecology of India 6/2019

01-12-2019 | Thrombocytopenia | Guest Editorial

Coagulopathies in Pregnancy: What an Obstetrician Ought to Know!

Author: Abhay A. Bhave

Published in: The Journal of Obstetrics and Gynecology of India | Issue 6/2019

Login to get access

Excerpt

It is a matter of concern if you read “33 women die every hour from pregnancy and childbirth complications - India among 10 nations with highest maternal mortality ratio” (WHO). Complications of pregnancy and childbirth are the leading causes of disability and death amongst women between the ages of 15 and 49. In a study conducted in Mumbai, more than half of the women suffer from various complications and were in the younger age hailing from rural areas [1]. …
Literature
1.
go back to reference Gogoi M. Pregnancy complications and birth outcome: do health care services make a difference? Int Res J Soc Sci. 2015; 4(3):27–35. Gogoi M. Pregnancy complications and birth outcome: do health care services make a difference? Int Res J Soc Sci. 2015; 4(3):27–35.
2.
go back to reference Bolte AC, Hermans FJ, Van Rheenen-Flach LE. [227-POS]: Thromboelastography (TEG®) and rotational thromboelastometry (ROTEM®) in pregnancy: a systematic review. Pregnancy Hypertens Int J Women's Cardiovascular Health.. 2015;5(1):114–5. Bolte AC, Hermans FJ, Van Rheenen-Flach LE. [227-POS]: Thromboelastography (TEG®) and rotational thromboelastometry (ROTEM®) in pregnancy: a systematic review. Pregnancy Hypertens Int J Women's Cardiovascular Health.. 2015;5(1):114–5.
3.
go back to reference Levi M. Disseminated intravascular coagulation (DIC) in pregnancy and the peri-partum period. Thromb Res. 2009;1(123):S63–S6464.CrossRef Levi M. Disseminated intravascular coagulation (DIC) in pregnancy and the peri-partum period. Thromb Res. 2009;1(123):S63–S6464.CrossRef
4.
go back to reference Erez O, Mastrolia SA, Thachil J. Disseminated intravascular coagulation in pregnancy: insights in pathophysiology, diagnosis and management. Am J Obstet Gynecol. 2015;213(4):452–63.CrossRef Erez O, Mastrolia SA, Thachil J. Disseminated intravascular coagulation in pregnancy: insights in pathophysiology, diagnosis and management. Am J Obstet Gynecol. 2015;213(4):452–63.CrossRef
5.
go back to reference Cortet M, Deneux-Tharaux C, Dupont C, Colin C, Rudigoz RC, Bouvier-Colle MH, Huissoud C. Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial. Br J Anaesth. 2012;108(6):984–9.CrossRef Cortet M, Deneux-Tharaux C, Dupont C, Colin C, Rudigoz RC, Bouvier-Colle MH, Huissoud C. Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial. Br J Anaesth. 2012;108(6):984–9.CrossRef
6.
go back to reference Gupta M, Feinberg BB, Burwick RM. Thrombotic microangiopathies of pregnancy: differential diagnosis. Pregnancy hypertension. 2018;1(12):29–34.CrossRef Gupta M, Feinberg BB, Burwick RM. Thrombotic microangiopathies of pregnancy: differential diagnosis. Pregnancy hypertension. 2018;1(12):29–34.CrossRef
8.
go back to reference American College of Obstetricians and Gynecologists. Task Force on Hypertension in Pregnancy Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ task force on hypertension in pregnancy. Obstet Gynecol. 2013 Nov;122(5):1122–31. American College of Obstetricians and Gynecologists. Task Force on Hypertension in Pregnancy Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ task force on hypertension in pregnancy. Obstet Gynecol. 2013 Nov;122(5):1122–31.
9.
go back to reference Furlan M, Robles R, Solenthaler M, Wassmer M, Sandoz P, Lämmle B. Deficient activity of von Willebrand factor–cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood. 1997;89(9):3097–103.CrossRef Furlan M, Robles R, Solenthaler M, Wassmer M, Sandoz P, Lämmle B. Deficient activity of von Willebrand factor–cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood. 1997;89(9):3097–103.CrossRef
10.
go back to reference Peyvandi F, Lavoretano S, Palla R, Feys HB, Vanhoorelbeke K, Battaglioli T, Valsecchi C, Canciani MT, Fabris F, Zver S, Réti M. ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission. Haematologica. 2008; 93(2):232–9.CrossRef Peyvandi F, Lavoretano S, Palla R, Feys HB, Vanhoorelbeke K, Battaglioli T, Valsecchi C, Canciani MT, Fabris F, Zver S, Réti M. ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission. Haematologica. 2008; 93(2):232–9.CrossRef
11.
go back to reference Benhamou Y, Baudel JL, Wynckel A, Galicier L, Azoulay E, Provôt F, Pène F, Mira JP, Presne C, Poullin P, Halimi JM. Are platelet transfusions harmful in acquired thrombotic thrombocytopenic purpura at the acute phase? Experience of the French thrombotic microangiopathies reference center. Am J Hematol. 2015;90(6):E127–E129129.CrossRef Benhamou Y, Baudel JL, Wynckel A, Galicier L, Azoulay E, Provôt F, Pène F, Mira JP, Presne C, Poullin P, Halimi JM. Are platelet transfusions harmful in acquired thrombotic thrombocytopenic purpura at the acute phase? Experience of the French thrombotic microangiopathies reference center. Am J Hematol. 2015;90(6):E127–E129129.CrossRef
12.
go back to reference N. James, A.C. George, Acquired TTP: Clinical Manifestations and Diagnosis, in: L.L. Leung(Ed.), UpToDate,UpToDate,Waltham, MA, 2017. Accessed on 22 Nov 2017 N. James, A.C. George, Acquired TTP: Clinical Manifestations and Diagnosis, in: L.L. Leung(Ed.), UpToDate,UpToDate,Waltham, MA, 2017. Accessed on 22 Nov 2017
13.
go back to reference Bruel A, Kavanagh D, Noris M, Delmas Y, Wong EK, Bresin E, Provôt F, Brocklebank V, Mele C, Remuzzi G, Loirat C. Hemolytic uremic syndrome in pregnancy and postpartum. Clin J Am Soc Nephrol. 2017;12(8):1237–47.CrossRef Bruel A, Kavanagh D, Noris M, Delmas Y, Wong EK, Bresin E, Provôt F, Brocklebank V, Mele C, Remuzzi G, Loirat C. Hemolytic uremic syndrome in pregnancy and postpartum. Clin J Am Soc Nephrol. 2017;12(8):1237–47.CrossRef
14.
go back to reference Chan WS, Lee A, Spencer FA, Chunilal S, Crowther M, Wu W, Johnston M, Rodger M, Ginsberg JS. D-dimer testing in pregnant patients: towards determining the next ‘level’ in the diagnosis of deep vein thrombosis. J Thromb Haemost. 2010;8(5):1004–111.PubMed Chan WS, Lee A, Spencer FA, Chunilal S, Crowther M, Wu W, Johnston M, Rodger M, Ginsberg JS. D-dimer testing in pregnant patients: towards determining the next ‘level’ in the diagnosis of deep vein thrombosis. J Thromb Haemost. 2010;8(5):1004–111.PubMed
15.
go back to reference Kuriya A, Piedimonte S, Spence AR, Czuzoj-Shulman N, Kezouh A, Abenhaim HA. Incidence and causes of maternal mortality in the USA. J Obstet Gynaecol Res. 2016;42(6):661–8.CrossRef Kuriya A, Piedimonte S, Spence AR, Czuzoj-Shulman N, Kezouh A, Abenhaim HA. Incidence and causes of maternal mortality in the USA. J Obstet Gynaecol Res. 2016;42(6):661–8.CrossRef
16.
go back to reference Leonhardt G, Gaul C, Nietsch HH, Buerke M, Schleussner E. Thrombolytic therapy in pregnancy. J Thromb Thrombolysis. 2006;21(3):271–6.CrossRef Leonhardt G, Gaul C, Nietsch HH, Buerke M, Schleussner E. Thrombolytic therapy in pregnancy. J Thromb Thrombolysis. 2006;21(3):271–6.CrossRef
17.
go back to reference Forestier F, Daffos F, Capella-Pavlovsky M. Low molecular weight heparin (PK 10169) does not cross the placenta during the second trimester of pregnancy study by direct fetal blood sampling under ultrasound. Thromb Res. 1984;34(6):557–60.CrossRef Forestier F, Daffos F, Capella-Pavlovsky M. Low molecular weight heparin (PK 10169) does not cross the placenta during the second trimester of pregnancy study by direct fetal blood sampling under ultrasound. Thromb Res. 1984;34(6):557–60.CrossRef
18.
go back to reference Kamel H, Navi BB, Sriram N, Hovsepian DA, Devereux RB, Elkind MS. Risk of a thrombotic event after the 6-week postpartum period. N Engl J Med. 2014;370(14):1307–15.CrossRef Kamel H, Navi BB, Sriram N, Hovsepian DA, Devereux RB, Elkind MS. Risk of a thrombotic event after the 6-week postpartum period. N Engl J Med. 2014;370(14):1307–15.CrossRef
19.
go back to reference Blondon M, Casini A, Hoppe KK, Boehlen F, Righini M, Smith NL. Risks of venous thromboembolism after cesarean sections: a meta-analysis. Chest. 2016;150(3):572–96.CrossRef Blondon M, Casini A, Hoppe KK, Boehlen F, Righini M, Smith NL. Risks of venous thromboembolism after cesarean sections: a meta-analysis. Chest. 2016;150(3):572–96.CrossRef
Metadata
Title
Coagulopathies in Pregnancy: What an Obstetrician Ought to Know!
Author
Abhay A. Bhave
Publication date
01-12-2019
Publisher
Springer India
Published in
The Journal of Obstetrics and Gynecology of India / Issue 6/2019
Print ISSN: 0971-9202
Electronic ISSN: 0975-6434
DOI
https://doi.org/10.1007/s13224-019-01290-8

Other articles of this Issue 6/2019

The Journal of Obstetrics and Gynecology of India 6/2019 Go to the issue